Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 3.20T | 3.52T | 1.21T | 1.02T | 936.66B | 791.75B |
Gross Profit | 2.27T | 1.85T | 1.13T | 892.43B | 777.97B | 674.12B |
EBITDA | 740.74B | 1.05T | 685.87B | 535.98B | 453.69B | 378.64B |
Net Income | 677.83B | 622.66B | 495.45B | 386.00B | 325.98B | 260.27B |
Balance Sheet | ||||||
Total Assets | 42.28T | 44.12T | 25.76T | 21.11T | 17.98T | 15.96T |
Cash, Cash Equivalents and Short-Term Investments | 2.31T | 7.15T | 7.24T | 5.99T | 5.32T | 4.13T |
Total Debt | 6.53T | 8.09T | 3.24T | 2.19T | 1.48T | 1.47T |
Total Liabilities | 37.10T | 36.23T | 22.84T | 18.60T | 15.82T | 14.07T |
Stockholders Equity | 5.02T | 4.56T | 2.91T | 2.50T | 2.16T | 1.89T |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 147.83B | 433.58B | 554.69B | 903.97B | 152.89B |
Operating Cash Flow | 0.00 | 190.69B | 477.20B | 581.02B | 921.78B | 171.18B |
Investing Cash Flow | 0.00 | -3.67T | -4.39T | -3.30T | -2.52T | -2.15T |
Financing Cash Flow | 0.00 | 3.35T | 4.17T | 2.91T | 1.92T | 1.85T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $212.15B | 11.24 | 10.83% | 3.26% | -1.91% | -6.79% | |
77 Outperform | $119.33B | 19.63 | 17.89% | 0.71% | 22.15% | 12.13% | |
76 Outperform | $157.60B | 13.33 | 6.30% | 2.63% | 2.97% | 87.82% | |
76 Outperform | $155.04B | 13.08 | 9.18% | 1.96% | 5.39% | 20.82% | |
76 Outperform | $258.71B | 14.28 | 11.05% | 2.00% | 3.51% | 16.51% | |
73 Outperform | $180.35B | 23.39 | 14.51% | 0.86% | 13.13% | 0.54% | |
64 Neutral | $6.62B | 10.86 | 6.59% | 5.05% | 24.65% | 0.99% |